Comparison of perioperative outcomes and technical features using da Vinci Si and Xi robotic platforms for early stages of endometrial cancer

2020 ◽  
Author(s):  
Andrea Giannini ◽  
Elisa Malacarne ◽  
Claudia Sergiampietri ◽  
Paolo Mannella ◽  
Alessandra Perutelli ◽  
...  
Keyword(s):  
Endometrial Cancer ◽  
Da Vinci ◽  
Perioperative Outcomes ◽  
Early Stages ◽  
Robotic Platforms ◽  
Technical Features ◽  
Da Vinci Si

scholarly journals Comparison of Perioperative Outcomes Using the da Vinci S, Si, X, and Xi Robotic Platforms for BABA Robotic Thyroidectomy

Medicina ◽  
2021 ◽  
Vol 57 (10) ◽  
pp. 1130
Author(s):  
Hye Rim Shin ◽  
Keunchul Lee ◽  
Hyeong Won Yu ◽  
Su-jin Kim ◽  
Young Jun Chai ◽  
...  
Keyword(s):  
Retrospective Study ◽  
Standard Method ◽  
Da Vinci ◽  
Operation Time ◽  
Robotic Thyroidectomy ◽  
Robotic Systems ◽  
Perioperative Outcomes ◽  
Da Vinci Xi ◽  
Cosmetic Results ◽  
Robotic Platforms

Background and Objectives: Robotic thyroidectomy via the bilateral axillo-breast approach (BABA), first introduced in Korea in 2008, has become a standard method of thyroid removal worldwide. The introduction of robotic surgical systems has enabled more patients to benefit from BABA robotic thyroidectomy, with good postoperative and excellent cosmetic results. To date, no studies have compared the benefits of the four currently available da Vinci robotic systems (S, Si, X, and Xi) for BABA robotic thyroidectomy. To determine the da Vinci model most suitable for BABA robotic thyroidectomy, the present study compared the perioperative outcomes in patients who underwent BABA robotic thyroidectomy using the four da Vinci models. Materials and Methods: This retrospective study evaluated outcomes in patients (n = 750) who underwent BABA robotic thyroidectomy using the four da Vinci systems from 2013 to 2019. The clinicopathologic data, including operation time, were compared. Substudy A compared the da Vinci models S and Si from 2013 to 2017, and substudy B compared models Si, X, and Xi from 2018 to 2019. Results: Substudy A, comparing the da Vinci S and Si systems, found no statistically significant differences between the two groups, whereas substudy B found that operation time was shorter in patients who underwent BABA robotic thyroidectomy with the da Vinci Xi system than with the Si and X systems. Conclusions: The da Vinci model Xi system can benefit patients undergoing BABA robotic thyroidectomy by shortening the operation time.

scholarly journals A comparison of the da Vinci Xi vs. da Vinci Si surgical systems for radical prostatectomy

BMC Surgery ◽  
2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Kun-Yang Lei ◽  
Wen-Jie Xie ◽  
Sheng-Qiang Fu ◽  
Ming Ma ◽  
Ting Sun
Keyword(s):  
Radical Prostatectomy ◽  
Da Vinci ◽  
Laparoscopic Radical Prostatectomy ◽  
Perioperative Outcomes ◽  
Da Vinci Xi ◽  
Robot Assisted ◽  
Short Term ◽  
Term Efficacy ◽  
Da Vinci Si ◽  
The Cost

Abstract Background To compare the perioperative and short-term efficacy and cost of the da Vinci Xi and da Vinci Si surgical systems for radical prostatectomy. Methods We retrospectively analyzed the clinical data of 175 patients with prostate cancer who underwent radical prostatectomy with the da Vinci Si or Xi surgical systems in our hospital from June 2019 to June 2020. Of the 175 patients, 82 underwent robot-assisted laparoscopic radical prostatectomy with the da Vinci Xi surgery system, and 93 patients underwent robot-assisted laparoscopic radical prostatectomy with the da Vinci Si surgical system. The perioperative outcomes, short-term efficacy and costs were compared between the two groups. Results The anesthesia time, operation time, docking time, indwelling catheter time and postoperative bed rest time in the Xi group were shorter than those in the Si group (respectively, 268.8 min vs. 219.3 min, P = 0.001; 228.2 min vs. 259.6 min, P < 0.001; 7.4 min vs. 12.7 min, P < 0.001; 8.6 d vs. 9.7 d, P = 0.036; 2.2 d vs. 2.6 d, P = 0.002). However, the total cost of hospitalization and the cost of intraoperative consumables in the Xi group were higher than those in the Si group (84,740.7 vs. 76,739.1 ¥, P = 0.003; 13,199.4 vs. 10,823.0 ¥, P = 0.019). Conclusions Although the cost of robot-assisted radical prostatectomy is higher, compared with the Si system, the Xi system has better perioperative outcomes and can provide similar short-term efficacy and oncology outcomes.

Colorectal Cancer Surgery Using the Da Vinci Xi and Si Systems: Comparison of Perioperative Outcomes

2018 ◽  
Vol 26 (2) ◽  
pp. 192-200 ◽  
Author(s):  
Yu-Min Huang ◽  
Yan Jiun Huang ◽  
Po-Li Wei
Keyword(s):  
Colorectal Cancer ◽  
Rectal Cancer ◽  
Da Vinci ◽  
Operation Time ◽  
Robotic System ◽  
Cancer Surgery ◽  
Perioperative Outcomes ◽  
Da Vinci Xi ◽  
Colorectal Cancer Surgery ◽  
Estimated Blood Loss

Purpose. Robotic surgery for colorectal cancer is an emerging technique. Potential benefits as compared with the conventional laparoscopic surgery have been demonstrated. However, experience with the previous da Vinci Si robotic system revealed several unsolved problems. The novel features of the new da Vinci Xi increase operational flexibility and maneuverability and are expected to facilitate the performance of multiquadrant surgery. Methods. Between December 2011 and May 2015, 120 patients with colon or rectal cancer were operated on using the Si robotic system (the Si group). Between May 2015 and October 2017, 60 more patients with colon or rectal cancer were operated on using the Xi robotic system (the Xi group). The clinicopathological characteristics and perioperative outcomes of these 2 groups of patients were compared. Results. The 2 groups of patients were comparable with regard to baseline clinical characteristics, types of resection performed, and the proportion of patients undergoing neoadjuvant chemoradiation therapy. The statuses of resection margin, the numbers of lymph nodes harvested, and the rates of postoperative complications were also similar between the 2 groups. Nevertheless, a lower rate of diverting ileostomy, a shorter operation time, less estimated blood loss, and a faster postoperative recovery was observed in the Xi group. Conclusions. Colorectal cancer surgery using the Xi robotic system was associated with improved perioperative outcomes. These benefits may be attributed to its improved, more user-friendly design.

scholarly journals Impact of Refractive Errors on Da Vinci SI Robotic System

2020 ◽  
Vol 24 (3) ◽  
pp. e2020.00031
Author(s):  
Mustafa Bilal Tuna ◽  
Ayse Ebru Kilavuzoglu ◽  
Panogiotis Mourmouris ◽  
Omer Burak Argun ◽  
Tunkut Doganca ◽  
...  
Keyword(s):  
Da Vinci ◽  
Robotic System ◽  
Refractive Errors ◽  
Da Vinci Si

scholarly journals A Scoping Review of Emerging and Established Surgical Robotic Platforms With Applications in Urologic Surgery

2021 ◽  
pp. 300-310
Author(s):  
Braden Millan ◽  
Shavy Nagpal ◽  
Maylynn Ding ◽  
Jason Y. Lee ◽  
Anil Kapoor
Keyword(s):  
Da Vinci ◽  
Da Vinci Surgical System ◽  
Pubmed Central ◽  
Urologic Surgery ◽  
Additional Information ◽  
Surgery Research ◽  
Robotic Platforms ◽  
Distinct Features ◽  
Vinci Surgical System ◽  
Surgical System

Objectives Since the introduction of the first master–slave robotic platform for surgical procedures, there have been ongoing modifications and development of new platforms, but there is still a paucity of commercially available systems. Our study aims to identify all master–slave robotic surgical platforms currently commercially available or in development around the world with applications in urologic surgery. Methods A scoping literature search was performed using PRISMA methodology to identify all relevant publications in English in PubMed, PubMed Central, and Embase, with additional information being obtained from official company websites. Results Ten robotic platforms with either proven or potential application in urologic surgery were identified: the da Vinci surgical system (Intuitive), Senhance surgical system (Transentrix), Versius Surgical (CMR Ltd), Enos surgical system (Titan Medical), Revo –I (Meere Company), MiroSurge (DLR), Avatera System (Avatera Medical), Hugo Surgical Robot (Medtronic), Ottava (J&J, Ethicon, Areus), and Hinotori (Medicaroid Corporation). Conclusions This review highlights the distinct features of emerging master–slave robotic platforms with applications in urologic surgery. Research and development are now focused on finding wider applications, improving outcomes, increasing availability, and reducing cost. Additional research is required comparing newly developed master–slave robotic platforms with those already well established.

Sign in / Sign up

Export Citation Format

Share Document